The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus
Stephanie M Robert,Benjamin C Reeves,Emre Kiziltug,Phan Q Duy,Jason K Karimy,M Shahid Mansuri,Arnaud Marlier,Garrett Allington,Ana B W Greenberg,Tyrone DeSpenza Jr,Amrita K Singh,Xue Zeng,Kedous Y Mekbib,Adam J Kundishora,Carol Nelson-Williams,Le Thi Hao,Jinwei Zhang,TuKiet T Lam,Rashaun Wilson,William E Butler,Michael L Diluna,Philip Feinberg,Dorothy P Schafer,Kiavash Movahedi,Allen Tannenbaum,Sunil Koundal,Xinan Chen,Helene Benveniste,David D Limbrick Jr,Steven J Schiff,Bob S Carter,Murat Gunel,J Marc Simard,Richard P Lifton,Seth L Alper,Eric Delpire,Kristopher T Kahle
DOI: https://doi.org/10.1016/j.cell.2023.01.017
IF: 64.5
2023-02-16
Cell
Abstract:The choroid plexus (ChP) is the blood-cerebrospinal fluid (CSF) barrier and the primary source of CSF. Acquired hydrocephalus, caused by brain infection or hemorrhage, lacks drug treatments due to obscure pathobiology. Our integrated, multi-omic investigation of post-infectious hydrocephalus (PIH) and post-hemorrhagic hydrocephalus (PHH) models revealed that lipopolysaccharide and blood breakdown products trigger highly similar TLR4-dependent immune responses at the ChP-CSF interface. The resulting CSF "cytokine storm", elicited from peripherally derived and border-associated ChP macrophages, causes increased CSF production from ChP epithelial cells via phospho-activation of the TNF-receptor-associated kinase SPAK, which serves as a regulatory scaffold of a multi-ion transporter protein complex. Genetic or pharmacological immunomodulation prevents PIH and PHH by antagonizing SPAK-dependent CSF hypersecretion. These results reveal the ChP as a dynamic, cellularly heterogeneous tissue with highly regulated immune-secretory capacity, expand our understanding of ChP immune-epithelial cell cross talk, and reframe PIH and PHH as related neuroimmune disorders vulnerable to small molecule pharmacotherapy.